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Abstract
We present the pathologic findings in the adrenal glands of 4 patients, aged 10 to 38 years, with
Cushing syndrome and germline inactivating mutations of the gene PDE11A4 that encodes
phosphodiesterase11A4. The gene is expressed in the adrenal cortex and catalyses the hydrolysis
of cyclic adenosine monophosphate and cyclic guanosine monophosphate. Two of the patients
were mother and daughter; the third had no affected relative; the fourth patient inherited the
mutation from her father. Three of the group, including the mother and daughter, had the same
pathology, primary pigmented nodular adrenocortical disease, a disorder known to be caused by
inactivating mutations of the PRKAR1A gene. In these cases, the adrenal glands were small and
the pathologic change was deep in the cortex in which numerous pigmented micronodules
developed. In the remaining patient, the glands were slightly enlarged primarily owing to a diffuse
hyperplasia of the superficial cortex that extended into the epi-adrenal fat.
Keywords
Cushing syndrome; PDE11A mutation; primary pigmented nodular adrenocortical disease;
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In 1932, Harvey Cushing described the series of clinical findings that were later found to be
caused by corticotrophin (ACTH)-secreting basophil adenomas of the pituitary gland
(Cushing disease).5 The main features of the disorder were young age at onset, central
adiposity, kyphosis, and amenorrhea and impotence in females and males, respectively. It
emerged subsequently that this constellation of symptoms and signs could also be caused by
ACTH-independent conditions. In these, the primary cause of the manifestations almost
always lay in the adrenal cortex, owing either to a unilateral tumor (adenoma or carcinoma)
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or a bilateral disorder (macro-nodular cortical hyperplasia or diffuse and nodular hyperplasia
or primary pigmented nodular adrenocortical disease) (Cushing syndrome).15,18 Rarely, they
resulted from ectopic secretion of ACTH.11
Recently, genetic mutations responsible for several of the primary bilateral cortical disorders
have been identified. The nodular hyperplasia of the McCune-Albright syndrome12 is caused
by postzygotic somatic mutations in the GNAS gene.23 This gene encodes the α subunit of
the stimulatory G protein and mutation results in activation of the Gsα subunit,
uninterrupted stimulation of adenylyl cyclase, and persistently high levels of cyclic
adenosine monophosphate (cAMP). Primary pigmented nodular adrenocortical disease
(PPNAD), another primary bilateral adrenal cause of the Cushing syndrome,21 is caused by
inactivating germline mutations of the PRKAR1A gene.4,6,7,13 PRKAR1A encodes the type
1A regulatory subunit of cAMP-dependent protein kinase14; its inactivation results in
increased cAMP signaling.13 PPNAD occurs as a sporadic isolated condition,21 as a familial
disorder,6 and as a component of a multisystem tumorous familial syndrome, the Carney
complex.3,17,20,22
There is a residual group of patients with bilateral primary adrenocortical pathology and
Cushing syndrome with neither GNAS nor PRKAR1A gene mutations. A genome-wide scan
of patients with primary adrenal disease and their tissues identified inactivating mutations
disrupting the expression of a third gene, phosphodiesterase11A4 (PDE11A4), in 4 of them.8
This gene is located at chromosome area 2q31.2, expressed in the adrenal cortex among
other tissues and catalyses the hydrolysis of cAMP and cyclic guanosine monophosphate. In
another patient from this group, a mutation in another gene, PDE8B, was found.10 PDE8B is
located on chromosome 5q13 and catalyses the hydrolysis of cAMP.9 The mutations of the
GNAS, PRKAR1A, PDE11A, and PDE8B genes all result in increased AMP signaling.1
Herein, we describe the adrenal findings in the 4 patients with the PDE11A4 gene mutation,
1 PPNAD, the other indeterminate, possibly a variant of PPNAD.
PATIENTS AND METHODS
Patients
The 4 patients were females ranging in age from 10 to 38 years. Two (cases 1 and 2) were
related as mother and daughter. The third patient had no affected relative. The fourth patient
(case 4) inherited the mutation from her father; he had an enlarged adrenal gland but normal
results of adrenocortical testing and no Cushing syndrome. Three underwent bilateral
adrenalectomy. Unilateral adrenalectomy only was done in the case of patient 3 because
technical difficulty prevented excision of the second gland. Follow-up period ranged from 3
weeks to 25 years. Patients 1 and 2 were cured of Cushing syndrome. Patient 3 became
hypoadrenal postoperatively and initially required steroid support; presently, she is
eucortisolemic, but still has a paradoxical response to dexamethasone stimulation (although
less elevated than preoperatively) 5 years after the unilateral adrenalectomy. The fourth
patient died 3 weeks after surgery. Certain findings in case 1 were reported earlier.19
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Methods
Fresh specimen(s) of the adrenal cortex were obtained and frozen in each case for molecular
genetic studies8 after which the glands were immersed in 10% neutral buffered formalin.
Blocks of the fixed tissue were embedded in paraffin wax. Five micron-thick sections were
made for staining with the hematoxylin and eosin (H&E) method and immunostaining with
antibodies directed against synaptophysin (ICN, SY38, dilution 1/40, Dual Envision),
inhibin (Serotec, clone R1, dilution 1/60, Advance), melan A (Dako, clone 103, dilution
1/500 BRD, Advance), and vimentin (Dako, clone V9, dilution 1/500, Dual Envision). The
number of sections of the glands available in the cases was 5, 17, 3 (unilateral
adrenalectomy), and 6, respectively. Cortical thickness was measured at 100× magnification,
using a 1 cm ocular reticule divided into 100 units. The areas of cortex inside and outside
the adrenal capsule were determined by scanning sections with the Bacus Laboratories Slide
Scanner (Bacus Laboratories Inc., Lombard, Illinois). The BLISS system captured images at
480 × 752 pixel resolution (magnification × 10). Each final image was composed of multiple
tiles arranged to create a composite image. Computer-assisted analysis of the images was
carried out using the Website Browser (Bacus Laboratories) that permitted outlined areas to
be measured in square millimeters.
RESULTS
Clinical, Imaging, Laboratory, Genetic Findings
Selected results are presented in Table 1.
Pathology
Gross—The weights of the adrenal glands, gross findings, and the original pathologic
diagnoses are shown in Table 2. The findings were similar in cases 1, 2, and 3. The cut
surface of the gland resected in case 3 is shown in Figure 1A.
Microscopic—The microscopic findings were similar in cases 1, 2, and 3 and will be
presented together to avoid repetition. The findings in case 4 were different and are
described separately. Selected findings in the 4 cases are displayed in Table 3 and
cytoplasmic immunocytochemical results in Table 4.
Cases 1, 2, and 3—H & E staining showed that the cortex was occupied by numerous,
small, round, and oval nodules and irregularly shaped zones of enlarged cortical cells, many
of which were situated in the deep cortex protruding into the medulla (Fig. 1). The nodules
ranged from less than 1 to 4mm in diameter and were confined within the capsule of the
gland. The cells had finely or coarsely granular eosinophilic cytoplasm; commonly, cells
with clear vacuolated cytoplasm were admixed; some nodules featured fatty metaplasia.
Many of the cells contained lipochrome. The nuclei were larger than those of the extra-
nodular cortical cells and had open chromatin pattern. Scattered nuclei were considerably
enlarged, hyperchromatic, and had prominent nucleoli. The low-power microscopic and
corresponding diagrammatic appearance of a transverse section of the adrenal resected in
case 3 are shown in Figures 1B and C.
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The cortex between the nodules was composed of small cells with vacuolated cytoplasm;
differentiation of the cortex into the zona fasciculata and zona reticularis was altered or lost.
The amount of remaining full thickness cortex varied. In case 3, only 2 measurements were
possible because of almost total replacement of the cortex by nodules (Table 3). The adrenal
capsule was intact. There was a very occasional small poorly circumscribed cortical
excrescence in the periadrenal fat (Figs. 1B–D) composed of enlarged eosinophilic cells, the
largest measured 0.2 mm.
Case 4—The cortex was 0.6-mm thick (average of 23 random measurements) [normal
thickness at age 10 y, 0.5mm (average of 50 random measurements, range=0.3 to 0.8 mm)].
The low-power microscopic and corresponding diagrammatic appearances of the patient’s
left adrenal gland are presented in Figure 2. The normal sharp distinction between the zona
fasciculata (vacuolated clear cells in columns) and zona reticularis (granular eosinophilic
cells in reticular pattern) was lost because of the presence of cells with mixed lightly
eosinophilic and clear cytoplasm (hybrid cells) in both zones. There were scattered well-
defined PPNAD-type nodules in the mid and deep cortex (Fig. 2B); some protruded into the
medulla; some coalesced. The nodules (Fig. 3A) were composed of large cells with granular
eosinophilic, rarely intensely eosinophilic cytoplasm. The nuclei were regular with
moderate-sized nucleoli. A few nodules showed fatty metaplasia and occasional
lymphocytes. There was a rare clear cell nodule (Fig. 3B). One nodule had cytoplasmic
lipochrome. Occasional groups of cells showed differential cytoplasmic staining, featuring
an eosinophilic periphery and an amphophilic or weakly basophilic center (Fig. 2C).
Cortical cells protruded into the lumen of the central vein.
There were 2 capsular abnormalities: (1) absence of capsule (gaps) for distances up to
1.3mm with extension of the hyperplastic intraadrenal cortical parenchyma through the
defect into the epi-adrenal fat (Figs. 2A, B, 3B). The interruptions in the capsule were not
caused by expanding cortical nodules. Elsewhere, the continuity of the capsule was
maintained but in places its collagen bundles were separated by cortical cells; here, the
capsule seemed to be undergoing gradual dissolution (Fig. 3D). A few capsular “pockets” of
cortical cells were present, some with cells in short linear array, findings that were regarded
as normal.2
The cortical protrusions into the epi-adrenal fat measured up to 2mm in dimension; some
were confluent (Figs. 2A, B). The cells had granular eosinophilic cytoplasm and were
arranged in sheets with occasional well-defined PPNAD-type nodules, 1 of which had very
large and huge cells containing lipochrome. The protrusions were usually solid and sharply
circumscribed from the retroperitoneal fat, and occasionally partially limited by a
pseudocapsule. Elsewhere, cortical cells percolated among retroperitoneal adipocytes
without stromal response.
Immunostaining results are presented in Table 4 and Figure 4.
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DISCUSSION
We have presented the pathology in the adrenal glands of 4 patients with Cushing syndrome
caused by inactivating mutations of the PDE11A4 gene. PDE11A4 is one of an 11-member
gene family, PDE1—PDE11. PDE11A4 codes for a dual-specificity cyclical nucleotide
phosphodiesterase, an enzyme that catalyses the hydrolysis of phosphodiester bonds.
The first genetic abnormalities identified as causative of primary bilateral nodular adrenal
hyperplasia and the Cushing syndrome were activating mutations of the GNAS gene in the
McCune-Albright syndrome.23 More recently, a series of inactivating mutations of the
PRKAR1A gene13 were identified as causative of PPNAD, a different Cushing syndrome-
associated pathologic phenotype. It seemed possible that the Cushing syndrome associated
with the PDE11A4 gene mutations might result in 1 of the foregoing pathologies.
In fact, 3 of the 4 patients (cases 1, 2, and 3) had PPNAD, a mother and her daughter with
the same PDE11A4 gene mutation, and a third unrelated patient with a different PDE11A4
mutation. In these patients, the glands were small [largest total adrenal weight=6.9 gm
(normal=8 to 9 gm)]. Nodules of large eosinophilic cells with lipochrome were present in
the zona reticularis often straddling the corticomedullary junction. There was very minor
involvement of the superficial cortex evidenced by a few transcapsular cortical extensions
into the periadrenal fat.
The findings in the remaining patient (case 4) were very different. The adrenal glands were
slightly enlarged owing to hyperplasia of the superficial cortex that protruded through gaps
in the adrenal capsule into the periadrenal fat in which large extracapsular aggregates of
cortical cells were present, some sharply circumscribed, others lacked circumscription and
percolated between retroperitoneal fat cells. A few PPNAD-type nodules were present in the
deep cortex. The patient inherited the PDE11A4 mutation from her father who had an
enlarged right adrenal gland but no Cushing syndrome and normal total glucocorticoid
secretion.
The most parsimonious interpretation of these findings is that the 4 patients all had PPNAD
because all exhibited small, pigmented adrenocortical nodules. However, the enlargement of
the glands in case 4 and the extensive involvement of the epi-adrenal fat were very different
from the findings in the other 3 cases, and from those in cases of sporadic PPNAD.21 Also,
some of the extranodular cortical immunocytochemical findings in case 4 differed for those
in the other 3 cases. In addition, the nodules in case 4 showed stronger staining with melan
A than in cases 1, 2, and 3. For these reasons, the findings in case 4 represent may not
represent PPNAD although this possibility cannot be ruled out; they may constitute a
different pathologic phenotype. As different mutations in the PRKARIA gene result in
different clinical phenotypes,7,16 it is possible that different PDE11A4 mutations could
cause different pathologic phenotypes. Further, PPNAD-type nodules are not diagnostic of
primary pigmented nodular adrenal disease; isolated ones may be encountered in normal
adrenal glands and multiple such nodules occur in idiopathic Addison disease21 and
adrenoleukodystrophy.24
Carney et al. Page 5
Am J Surg Pathol. Author manuscript; available in PMC 2014 June 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
In case 4, the protusion of the hyperplastic cortex through the capsule into the epi-adrenal fat
and the intravascular protrusion of the cortical cells could be interpreted as evidence of an
invasive and therefore, aggressive disorder. However, both of these findings are
occasionally encountered in normal adrenal glands2 and also in PPNAD.21 The extraadrenal
cortical extensions showed some evidence of pseudoencapsulation and did not evoke a host
stromal response, as might be expected with an infiltrating malignant neoplasm. This
extension of the cortical parenchyma beyond its capsular confines is an unusual, possibly
unique, form of pathologic parenchymal hypertrophy that may be limited to the adrenal
gland. The intravascular cortical protrusions in the case were likely related to the
discontinuous anatomy of the adrenal vein musculature and not evidence of malignancy.2
Several of the terms used in connection with adrenal cortical pathology lack precision—
micronodular and macronodular,15 for example—are imprecise or are arbitrarily defined.
The term “pigmented micronodular” is more specific but nodules that appear brown or black
grossly may not have lipochrome microscopically, as in case 4. And nodules that have much
lipochrome when examined microscopically likely had none at inception. Although the
patients described in this article all had small “pigmented” or “dark brown” nodules grossly,
the histopathology in the cases was not the same: the findings in case 4 were substantially
different from those in the other 3, as we have described.
The results of our study indicate a need to establish a morphogenetic classification scheme
for the Cushing syndrome-associated multiple types of primary bilateral adrenocortical
pathology that apparently exist.
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FIGURE 1.
(Case 3). Primary pigmented nodular adrenocortical disease. A, The cut surface of the fresh
gland displayed pigmented nodules, ranging in size from less than 1mm (arrows) to 3mm in
greatest dimension. B, Panoramic view of a microscopic transverse section of the adrenal
gland showed a normal shape with sharply defined outline. Many cortical nodules, several
confluent, and 3 small excrescences (arrows) were present. C, Diagrammatic representation
of the findings in B. Cortical micronodules are enclosed in circles. Cortical excrescences in
the periadrenal fat are shown in red. The medulla is depicted in green. D, The area in
rectangle in B showed that the cortex was completely replaced by a series of juxtaposed
nodules. A small cortical excrescence was present (arrow). This corresponds to the lesion
indicated by the upper arrow in B and C.
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FIGURE 2.
(Case 4). Primary adrenocortical hyperplasia with extraadrenal cortical extension. A,
Panoramic view of a microscopic transverse section of the left adrenal gland showed general
preservation of the shape of the gland but loss of the normal sharp peripheral outline because
of the presence of poorly circumscribed masses of cortical cells applied to the external
aspect of the capsule. B, Diagrammatic representation of the findings in A. The adrenal
capsule is indicated by a solid line, capsular attenuation by a broken line, and capsular
breaks by an absent line. Cortical micronodules are enclosed in circles and permeating
cortical excrescences indicated in red. The medulla is shown in green. The hyperplastic
cortex and extracapsular cortical parenchyma occupied approximately equal areas.
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FIGURE 3.
(Case 4). A, An irregularly shaped nodule with fatty metaplasia composed of large
eosinophilic and some vacuolated clear cells was present in the deep cortex abutting the
medulla (left). A very attenuated capsule separated the cortex proper from extracapsular
cortical tissue (upper right). B, A capsular break (upper portion of illustration) resulted in
continuity of the hyperplastic cortex proper (left) and a solid excrescence (right) that
contained 2 nodules, 1 with eosinophilic and the second with vacuolated clear cells (bottom
left). C, Cortical nodule was composed of large cells with eosinophilic (top right) and
amphophilic cytoplasm peripherally and centrally, respectively. D, The hyperplastic cortex
(right) was separated from a solid cortical excrescence (left) by the adrenal capsule whose
collagen bundles were separated by cortical cells.
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FIGURE 4.
Immunocytochemical results (case 3, A, C, E, and G; case 4, B, D, F, and H).
Synaptophysin. A, Many cortical nodules were stained, often strongly; the extranodular
cortex was unstained. The medulla was heavily stained. B, A vague cortical nodule (arrow)
was less heavily stained than those in case 3; there was patchy staining throughout the
extranodular cortex. Inhibin. C, Cortical nodules were strongly stained. Irregular clumps of
enlarged cells between the nodules were lightly stained (arrows). D, A cortical nodule was
strongly stained (arrow). There was patchy staining of the internodular cortex. Melan A. E,
Juxtaposed nodules were moderately stained. A subcapsular rim of cortical cells was heavily
stained. F, The outer cortex and extraadrenal cortical cells were stained. A nodule (arrow)
was stained. Vimentin. G, The extranodular cortex, particularly the superficial aspect, was
stained. Nodules were weakly stained or unstained. H, The intraadrenal and extraadrenal
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cortex were stained, but not as strongly as in case 3. A cortical nodule was not stained
(arrow).
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